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A number ofcDNA clones have been obtained in summary encoding the N-terminal domain containing 286 amino acid residues of the rabbit skeletal 
muscle a-actinin subunit. B-Actinin cDNA clones were isolated from specific cDNA libraries using the primer extension method for synthesis of 
the first cDNA chain. A strong stop signal for AMV reverse transcriptase in the 5’-tericinal region of mRNA of a-actinin was found. It seems 
there is a G+C rich region (93% G+C nucleotides) including a continuous sequence of 23 G and C nucleotides encoding 6 glycine residues. 
a-Actinin; Rabbit skeletal muscle; 96-Fold degenerate oligonucleotide mix; AMV reverse transcriptasc strong stop signal 
1. INTRODUCTION 
a-Actinin is a minor protein of contractile systems. It 
connects F-actin strands by cross-bridges and enhances 
ATPase activity and superprecipitation of actomyosin 
in vitro [1,2]. 
a-Actinin consists of 2 identical subunits (M, of each 
is about 100 kDa) [3]. During mild trypsinolysis each of 
the subunits divides into 2 parts, the N-terminal mono- 
mer (M,-30 kDa) and theC-terminal dimer (M,- 70 kDa 
of each chain). The N-terminal domain of each subunit 
is able to bind F-actin [+ -~ 1’1. 
The primary structures of &-actinins from different 
objects have been published [8-121. In this work we 
present the primary structure of the N-terminal domain 
of rabbit muscle a-actinin deduced from the nucleotide 
sequence of cDNA. C’qning of this cDNA was carried 
out as in [ 131 by creation of specific cDNA libraries. 
The strong stop signal for AMV reverse transcriptase 
has been found during synthesis of a-actinin cDNA. As 
in [13] this signal seems to be the G+C rich region of 
mRNA (in this case richer in G+C content than in [ 131). 
To overcome this problem we used, as in [13], the spe- 
cific oligonucleotide primer just before the G+C rich 
region of mRNA. 
2. MATERIALS AND METHODS 
2.1. Materials 
We used dNTP (Pharmacia). restriction endonucleases, the 5’-cnd- 
labelling kit (Boehringer Mannheim), [‘H]dCTP (32 Ci/mmol), RNA- 
sin, E. coli DNA polymerase I, ribonuclease H. T, DNA polymerase, 
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T4 DNA ligase, Ml3 cloning kit, M 13 sequencing kit, terminal deoxy- 
nucleotidyltransferase (Amersham) and avian myeloblastosis virus re- 
verse transcriptase (Vostok, USSR). 
2.2. Syntlresis of oligonucCeotides 
Oligonucleotides I and II were synthesized in accordance with the 
primary structure of rabbit muscle a-actinin fragments [5], and oligo 
III in accordance with the sequence, determined in this work, of 
a-actinin cDNA (Fig. I). Synthesis was performed on the Beckman 
System I DNA synthesizer. 
2.3. Isolarion of cr-actinin cDNA clones 
Specific libraries were created and screened as in [13], using oligo 
I and oligo III as primers and oligo II as a probe. The PstI-EcoRI 
restriction a-actinin cDNA fragment from plasmid pTZ-ARI-3a (Fig. 
2: fr727) and the short DNA fragment obtained by PCR. Amplilica- 
tion as in [14] was done using single strand M13mplO with insertion 
of the fr727 as a matrix, and reverse MI3 primer and oligo III as 
primers. 
2.4. Nuclcotide sequence determination 
DNA sequencing was carried out on both strands by the dideoxy 
chain termination method (IS]. Oligo 11(96-fold degenerated oligonu- 
c!eotide mix) was used as a sequencing primer. 
3. RESULTS AND DISCUSSION 
Oligos I and 11 were designed according to the pri- 
mary structure fragments of a-actinin previously deter- 
mined [S]. Using oligo I as a primer we created a specific 
library of 1500 clones and screened it using the probe 
oligo II (Fig. 1 and 2). Only the clone containing the 727 
bp a-actinin cDNA (fr727) was isolated and sequeno:d 
as in [15]. The use of degenerated oligonucleotide mixes 
(up to 64-fold) for DNA sequencing has been previously 
published [ 161. We successfully used the 96-fold degen- 
erated oligonucleotide mix oligo II as sequencing pri- 
mer (data not shown). 
After screening several specific cDNA libraries (total 
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Oligonucleotidos sequence 
01igo I, 17 mer. Acn Gln GIU Asn Glu Lye 
12-fold degen. 3' TTP-GTQ-CTQ-CTP-CIQ-TT 5' 
Oligo 11, 17 mer. Pho Ala Ile Gin Asp Ile 
96-fold degen. 5' TTQ-GCN-ATM-CAP-GAQ-AT 3' 
Oligo III, 
17 mer. 
11s Glu Glu Asp Phe Ary 
3' AG-CTC-CTC-CTG-AAG GCG 5' 
- 
Fig. 1. Amino acid sequence of protein fragments of rabbit muscle 
cl-actinin and the oligonucleotides encoding them. Q=C or T: P=A or 
G: N=T. C. G or A: and M = C. T or A. 
3000 clones), created in the same manner as before. 20 
positive clones were isolated (Fig. 2d: clones series 
pUC-ARI). All these clones had a-actinin coding se- 
quences with lengths shorter than the first cloned frag- 
ment fr727. and synthesis of 15 was interrupted near the 
same point as the fr727. We assumed that interruption 
of AMV reverse transcriptase synthesis of cDNA was 
due to the G+C rich region analogous to that ob- 
served in [13]. The oligo III, complementary to mRNA 
of a-actinin, was synthesized (Figs 2 and 3). The dis- 
tance between oligo III and the 5’4erminus of fr727 was 
87 bases. The specific cDNA was synthesized using this 
primer. then cloned and screened by the short cDNA 
fragment (~130 bp) containing the 5’-terminal 87 bp of 
fr727 obtained by PCR. Eight a-actinin cDNA clones 
were isolated from the library of only 200 clones. The 
lengths of cDNA of these clones ranged from -200 bp to 
-250 bp (Fig. 2e: clones series pUC-ARIlI). After se- 
quencing these fragmcii;s :!le primary structure of the 
ATG 1000 
whole N-terminal domain was derived. The initiator 
Met was determined as the first one encountered in the 
sequence. The length of the established amino acid se- 
quence is in good accordance with the lengths of tryptic 
peptides in [5]. In total, the sequence of 286 amino acid 
residues of the rabbit muscle cr-actinin N-terminus was 
determined (Figs 2b and 3). 
Analysis of the nucleotide sequence behind the point 
of interruption of synthesis of the first chain cDNA 
shows a G+C rich sequence of this region (95% G+C 
nucleotides) including a continuous sequence of 23 
G+C bases, encoding 6 Gly residues (Fig, 3). It seems 
that the regions with a high content of G-I-C bases are 
often a strong stop signal during cDNA synthesis [13]. 
Using oligonucleotide primers complementary to the 
mRNA just prior to the G+C rich regions solves these 
problems [13]. 
The deduced amino acid sequence of rabbit muscle 
cr-actinin is in good accordance with the data on the 
N-terminal amino acid sequence of tryptic fragments 
T,-Tg of ol-actinin obtained in the work of Simonidze 
et al. [5]. 
A comparison of the primary structure of the N- 
terminal domain of rabbit muscle a-actinin in this work 
v:ith the primary structures from other objects [S--12] 
revealed the high homology of these proteins with the 
exception that the N-terminal sequence (from the first 
to the twenty-fourth amino acid residue) is completely 
different. This is probably connected with the species or 
tissue specificity of the given kind of cr-actinin. 
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Fig. 2. (a) Scheme of poly(A)’ mRtiA of rabbit muscle r-actinia. (b) Schcmc of the cDNA Y-terminal region encoding the &-terminal domnin 
of the rabbit muscle a-actinin subunit. Arrows indicate G+C rich region. I. II. 111 are regions corresponding to oliponucleotidcs 1. II and III. (c) 
The a-aclinin 727 bp cDNA fragment from the pTZ-ARI-31 clone. (d) a-Actinin cDNA from clones scrics pUC-ARI. Four clones ol’thc 20 studied 
are shown. (c) a-Actinin cDNA from clone scrics pUC-ARIII. Three clones of the S studied ;Irc showy 
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shows the G+C rich region 
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